MRI Contrast Agents in Glycobiology

Review (2022)
Authors

Carlos F.G.C. Geraldes (Universidade de Coimbra, CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, Coimbra)

Joop Peters (TU Delft - BT/Biocatalysis)

Research Group
BT/Biocatalysis
Copyright
© 2022 Carlos F.G.C. Geraldes, J.A. Peters
To reference this document use:
https://doi.org/10.3390/molecules27238297
More Info
expand_more
Publication Year
2022
Language
English
Copyright
© 2022 Carlos F.G.C. Geraldes, J.A. Peters
Research Group
BT/Biocatalysis
Issue number
23
Volume number
27
DOI:
https://doi.org/10.3390/molecules27238297
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Molecular recognition involving glycoprotein-mediated interactions is ubiquitous in both normal and pathological natural processes. Therefore, visualization of these interactions and the extent of expression of the sugars is a challenge in medical diagnosis, monitoring of therapy, and drug design. Here, we review the literature on the development and validation of probes for magnetic resonance imaging using carbohydrates either as targeting vectors or as a target. Lectins are important targeting vectors for carbohydrate end groups, whereas selectins, the asialoglycoprotein receptor, sialic acid end groups, hyaluronic acid, and glycated serum and hemoglobin are interesting carbohydrate targets.